http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-35203-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_232361c9031a709144573276863c462b |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 |
filingDate | 1970-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1975-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | IE-35203-B1 |
titleOfInvention | Steroid-containing pharmaceutical preparations |
abstract | 1317184 Injectable anaesthetics GLAXO LABORATORIES Ltd 11 June 1970 [20 June 1969] 31371/69 Heading A5B [Also in Division C2] Anaesthetic compositions suitable for use by parenteral administration comprise an aqueous solution containing at least 1mg/ml of 3α- hydroxy-5α-pregnane-11, 20-dione and a non- ionic surface-active agent serving to solubilize the steroid. Preferably they contain at least 1% by weight of the agent and this has an HLB value of 9-18. Suitable agents include polyoxyethylated derivatives of fatty glyceride oils, polyoxyethylene ethers of long-chain alcohols, polyoxyethylene - polyoxypropylene ethers, polyoxyethylene ethers of alkyl phenols, polyoxyethylated fatty acid esters of sugar alcohol anhydrides, long-chain alkanoyl mono- and di-alkanolamides and polyethylene glycol esters of long-chain fatty acids. The solubility of the anaesthetic steroid may be further increased by addition of a steroid of the formula: wherein R is an optionally substituted alkanoyl, aroyl or aralkanoyl group. These steroids are described and claimed in Specification 1317185. They also possess some anaesthetic activity.n[GB1317184A] |
priorityDate | 1969-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.